Kit Simpson to AIDS-Related Opportunistic Infections
This is a "connection" page, showing publications Kit Simpson has written about AIDS-Related Opportunistic Infections.
Connection Strength
0.096
-
Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Value Health. 2000 May-Jun; 3(3):186-201.
Score: 0.042
-
Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques. Qual Life Res. 1995 Aug; 4(4):309-18.
Score: 0.030
-
The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratios. Pharmacoeconomics. 2004; 22(18):1209-16.
Score: 0.014
-
Impact of zidovudine-based triple combination therapy on an AIDS drug assistance program. J Acquir Immune Defic Syndr. 2000 Apr 01; 23(4):302-13.
Score: 0.010